Moran Wealth Management LLC Has $7.85 Million Stake in Fresenius Medical Care AG & Co. KGaA $FMS

Moran Wealth Management LLC lifted its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 31.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 347,773 shares of the company’s stock after buying an additional 83,311 shares during the period. Moran Wealth Management LLC’s holdings in Fresenius Medical Care AG & Co. KGaA were worth $7,846,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in FMS. CIBC Private Wealth Group LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 398.2% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 1,380 shares of the company’s stock worth $36,000 after acquiring an additional 1,103 shares during the period. Arax Advisory Partners lifted its position in shares of Fresenius Medical Care AG & Co. KGaA by 121.6% during the 4th quarter. Arax Advisory Partners now owns 1,613 shares of the company’s stock valued at $38,000 after acquiring an additional 885 shares during the period. Kestra Advisory Services LLC acquired a new stake in shares of Fresenius Medical Care AG & Co. KGaA during the 4th quarter worth $48,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Fresenius Medical Care AG & Co. KGaA during the 4th quarter worth $58,000. Finally, Group One Trading LLC acquired a new stake in shares of Fresenius Medical Care AG & Co. KGaA during the 3rd quarter worth $74,000. 8.37% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

FMS has been the subject of a number of analyst reports. Weiss Ratings downgraded Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, May 7th. Wall Street Zen downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Zacks Research downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 27th. Morgan Stanley reissued an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, May 6th. Finally, Citigroup restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Friday, April 24th. Four analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Strong Sell” and a consensus target price of $28.00.

Fresenius Medical Care AG & Co. KGaA Trading Up 0.1%

Shares of FMS stock opened at $23.55 on Friday. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of $20.02 and a fifty-two week high of $28.21. The stock’s fifty day moving average price is $22.33 and its two-hundred day moving average price is $22.84. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.86 and a current ratio of 1.20. The company has a market cap of $12.65 billion, a PE ratio of 12.39, a P/E/G ratio of 4.25 and a beta of 0.78.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its quarterly earnings results on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%.The company had revenue of $5.34 billion during the quarter. Equities analysts predict that Fresenius Medical Care AG & Co. KGaA will post 2.24 EPS for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The firm also recently announced an annual dividend, which was paid on Monday, June 8th. Shareholders of record on Friday, May 22nd were given a $0.8716 dividend. This is a boost from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. This represents a yield of 402.0%. The ex-dividend date was Friday, May 22nd. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio (DPR) is presently 32.11%.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.